(S)-N-Boc-2,3-氨基环氧丙烷, 99%

(S)-1-(tert-butoxycarbonyl)-2,3-oxiranylmethylamine

(S)-(+)-2-苯基丁酸, 99.9%

(S)-(+)-2-Phenylbutyric acid

4-溴-2-异丙氧基吡啶, 99%

4-Bromo-2-isopropoxypyridine

(R)-3,3'-二苯基-1,1'-联萘酚膦酸酯, ≥99%,99.9%e.e.

(11bR)-4-Hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(S)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol, ≥99%,99.9%e.e.

(S)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol

(S)-(-)-N,N-二甲基-1-二茂铁基乙胺, >97.0%(GC)

(S)-(-)-N,N-Dimethyl-1-ferrocenylethylamine

(3-溴-6-氯吡啶-2-基)甲醇

(3-Bromo-6-chloropyridin-2-yl)methanol

99%

(R)-3,3'-二苯基-[2,2'-联二萘]-1,1'-二醇, 99%

(2R)-3,3'-Diphenyl[2,2'-binaphthalene]-1,1'-diol

2-氨基-5-氟吡啶-3-腈

2-Amino-5-fluoronicotinonitrile

99%

(R)-3,3'-双(1-芘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚磷酸酯, ≥99%,99.9%e.e.

(11bR)​-8,​9,​10,​11,​12,​13,​14,​15-Octahydro-​4-​hydroxy-​2,​6-​di-​1-​pyrenyl-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin

(3aS,8aS)-(+)-4,4,8,8-四(3,5-二-异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧杂环戊烯并[4,5-e]二氧杂磷杂环庚烷, 99%

(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin

(3aS,8aS)-(+)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧杂环戊烯并[4,5-e]二氧杂磷杂环庚烷, 99%

(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-dimethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin

(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99.9%e.e.

(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

3-溴-4-氯苯甲酸甲酯, 98%

Methyl 3-bromo-4-chlorobenzoate

3-碘-4-硝基苯酚, 98%

3-Iodo-4-nitrophenol

(11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥99%,99.9%e.e.

(11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(1R,3S,4S)-N-Boc-2-氮杂双环[2.2.1]庚烷-3-羧酸, 98%

(1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid

(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥99%,99.9%e.e.

(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(3R)-(-)-3-(1-甲基-1H-吲哚-3-基)丁醛, 98%

(3R)-(-)-3-(1-Methyl-1H-indol-3-yl)butyraldehyde

(S)-1-(3-(叔丁基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯-4-基)-2,5-二苯基-1H-吡咯, 98%

(S)-1-(3-(Tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-4-yl)-2,5-diphenyl-1H-pyrrole